Back to results
US 2019/0055274 A1Published application
Ferric organic compounds, uses thereof and methods of making same
AssigneePanion & BF Biotech Inc.
InventorsDavid W.K. KWOK, Nikolay Mintchev STOYNOV
Life of this patent
Estimating the term…
Abstract
The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.
Claims10
1-81. (canceled)
A method of treating metabolic acidosis, comprising:
- administering a therapeutically effective amount of an orally administrable form of ferric citrate to a subject,
- wherein the orally administrable form is prepared from a form of ferric citrate having a BET active surface area greater than 16 sq. m/g.
Dependencies are inferred from the claim text.